ADGRG1 and central nervous system cancer: Ohta et al. developed agonistic Abs specific to GPR56-ECR and showed that GPR56 activation in the U87-MG human glioma cell line by these agonistic Abs lead to retarded cell migration via a Gαq-Rho signaling pathway [45].